Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ONCY holding history

Oncolytics Biotech Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ONCY overviewAll 13F holders of ONCYFull Q2 2026 holdings

Shares (Q2 2026)
31,096
Value
$29.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ONCY by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202631,096$29.5K<0.1%−19,463−38.5%ReducedHolders
Q1 202650,559$42.9K<0.1%+27,663+120.8%AddedHolders
Q4 202522,896$20.0K<0.1%00.0%UnchangedHolders
Q3 202522,896$32.1K<0.1%+2,100+10.1%AddedHolders
Q2 202520,796$16.1K<0.1%−102−0.5%ReducedHolders
Q1 202520,898$11.5K<0.1%00.0%UnchangedHolders
Q4 202420,898$19.1K<0.1%−2,038−8.9%ReducedHolders
Q3 202422,936$20.0K<0.1%+17,333+309.4%AddedHolders
Q2 20245,603$5.55K<0.1%+4,439+381.4%AddedHolders
Q1 20241,164$1.23K<0.1%−3,535−75.2%ReducedHolders
Q4 20234,699$6.34K<0.1%−2,966−38.7%ReducedHolders
Q3 20237,665$16.7K<0.1%−5,789−43.0%ReducedHolders
Q2 202313,454$35.0K<0.1%+4,304+47.0%AddedHolders
Q1 20239,150$11.0K<0.1%+1,485+19.4%AddedHolders
Q4 20227,665$12.5K<0.1%00.0%UnchangedHolders
Q3 20227,665$9.00K<0.1%−2,558−25.0%ReducedHolders
Q2 202210,223$11.0K<0.1%+10,058+6,095.8%AddedHolders
Q1 2022165$00.0%−3,140−95.0%ReducedHolders
Q4 20213,305$4.00K<0.1%−23,485−87.7%ReducedHolders
Q3 202126,790$56.0K<0.1%+6,101+29.5%AddedHolders
Q2 202120,689$57.0K<0.1%+18,577+879.6%AddedHolders
Q1 20212,112$8.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.